Additionally, the combined expression of miR-186 and its downstream target PTTG1 (pituitary tumor-transforming 1) has shown predictive value for tumor infiltration and invasion in colorectal neuroendocrine tumors, with detection possible through non-invasive blood and stool tests (34). The gene discussed is PTTG1; the disease is colorectal neuroendocrine tumor.